Skip to main content
letter
. 2018 Jun 11;8(6):55. doi: 10.1038/s41408-018-0081-8

Fig. 1. Overall Survival with azacitidine therapy.

Fig. 1

a KM estimates of OS for the azacitidine arm of each of the four articles, as well as the overall curve when all the individual level patient data are combined into one group (n = 411). b KM estimates of and numbers at risk for the pooled individual patient level data for patients who received azacitidine monotherapy in clinical trials